Vista Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.33	7.33	0.94	2.04	0.72	1.4
Cash & Short-Term Investments	1.33	7.33	0.94	2.04	0.72	1.4
Cash Growth	-94.97%	676.80%	-53.70%	183.59%	-48.68%	-37.79%
Accounts Receivable	41.3	33.93	41.88	112.51	104.64	21.69
Other Receivables	-	10.53	8.71	11.48	9.83	9.55
Receivables	41.3	50.02	50.64	124.77	137.38	54.15
Inventory	76.15	82.2	67.86	76.77	93.28	96.82
Prepaid Expenses	-	-	0.04	-	-	-
Other Current Assets	39.05	8.03	13.53	33.93	4.25	-
Total Current Assets	157.83	147.58	133.02	237.51	235.63	152.37
Property, Plant & Equipment	196.35	192.86	195.84	195.14	188.61	194.62
Long-Term Investments	0.73	0.45	0.21	0.17	0.31	0.41
Other Intangible Assets	95.53	95.53	95.53	95.53	95.53	-
Long-Term Accounts Receivable	82.04	101.52	100.93	-	-	-
Long-Term Deferred Tax Assets	55.89	43.73	33.09	26.44	34.82	-17.53
Long-Term Deferred Charges	-	-	-	-	-	95.53
Other Long-Term Assets	21.23	21.23	21.16	5.51	1	83.14
Total Assets	609.59	602.9	579.79	560.29	555.9	508.54
Accounts Payable	58.84	55.95	74.05	78.03	53.67	51.05
Accrued Expenses	0.3	9.16	12.07	3.58	10.13	6.58
Short-Term Debt	-	32.03	19.18	19.89	31.84	20.19
Current Portion of Long-Term Debt	62.42	18.21	31.14	27.91	19.42	-
Other Current Liabilities	17.77	8.31	8.48	11.42	11.35	14.64
Total Current Liabilities	139.32	123.66	144.92	140.82	126.39	92.46
Long-Term Debt	22.6	23.8	29.33	51.79	74.26	86.93
Pension & Post-Retirement Benefits	1.27	1.21	0.92	0.6	0.72	0.69
Other Long-Term Liabilities	0	0	-	-0	-	0
Total Liabilities	163.2	148.67	175.17	193.22	201.37	180.08
Common Stock	123.1	123.1	94.33	75.11	73.59	73.59
Additional Paid-In Capital	-	473.97	358.87	282.01	275.9	275.9
Retained Earnings	-	-151.2	-104.71	-59.59	-2.97	-29.14
Comprehensive Income & Other	323.29	8.35	56.13	69.55	8.01	8.11
Shareholders' Equity	446.39	454.23	404.62	367.08	354.53	328.46
Total Liabilities & Equity	609.59	602.9	579.79	560.29	555.9	508.54
Total Debt	85.02	74.04	79.65	99.59	125.51	107.12
Net Cash (Debt)	-83.69	-66.71	-78.7	-97.55	-124.79	-105.72
Net Cash Per Share	-1.43	-1.13	-1.80	-2.65	-3.39	-3.05
Filing Date Shares Outstanding	61.63	61.55	47.16	61.55	36.79	36.79
Total Common Shares Outstanding	61.63	61.55	47.16	37.56	36.79	36.79
Working Capital	18.51	23.92	-11.9	96.68	109.23	59.91
Book Value Per Share	7.24	7.38	8.58	9.77	9.64	8.93
Tangible Book Value	350.86	358.7	309.09	271.55	259	328.46
Tangible Book Value Per Share	5.69	5.83	6.55	7.23	7.04	8.93
Land	-	0.99	0.99	0.99	0.99	0.99
Buildings	-	65.42	65.42	65.42	65.42	65.42
Machinery	-	109.9	108.67	105.67	95.43	95.28
Construction In Progress	-	101.35	98.19	93.29	90.83	90.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.